SWOG Network Group Operations Center of the NCTN

NCTN SWOG 网络集团运营中心

基本信息

批准号：
8605343
负责人：
CHARLES D. BLANKE
金额：
$ 1382.91万
依托单位：
OREGON HEALTH & SCIENCE UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
2014
资助国家：
美国
起止时间：
2014-04-17 至 2019-02-28
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/8605343
关键词：
Accountability Address Adolescent Adult Advisory Committees Advocate Anatomy Applications Grants Behavior Canada Categories Clinical Clinical Sciences Clinical Trials Clinical Trials Network Collaborations Communication Communities Complement Conduct Clinical Trials Data Reporting Development Disease Ensure Ethics Fostering Foundations Funding Generations Goals Histologic International Korea Latin America Lead Leadership Malignant Neoplasms Mentors Mission Monitor Participant Pathway interactions Patient advocacy Patients Policies Prevention Principal Investigator Process Program Development Quality of life Recording of previous events Reporting Research Research Personnel Resources Running Safety Saudi Arabia Science Scientist Site Southwest Oncology Group Speed Structure Training Support United States Food and Drug Administration Work anticancer research cancer therapy design improved innovation international center meetings member neoplastic operation programs public health relevance research study survivorship tool translational clinical trial translational medicine translational study working group young adult

项目摘要

DESCRIPTION (provided by applicant): SWOG is a research organization with cancer investigators distributed across 550 academic and community sites throughout the U.S. Canada, Latin America, Korea, and Saudi Arabia. The Group has a long history of conducting clinical trials that have changed standard of oncologic practice and that have led to Food and Drug Administration approval of new anti-neoplastic agents. SWOG's mission is to design, direct and participate in clinical trials that will result in effective prevention and treatment of cancer in the process improving quality of life and quality of survivorship for those with malignancies. Guiding principles used to help achieve these goals include placing patients as our highest priority, using the best science to drive our research, embracing diversity in membership and leadership, demanding ethical behavior, and fostering young investigators. SWOG's specific aims for this application include Improving efficiency and rapidly executing the clinical trial development and conduct processes; collaborating widely to reduce accrual barriers and facilitate participation in NCTN trials; maximizing potential from international partners by studying globally-significant cancers; and being active participants and leaders in NCTN management. Building on our successful past while significantly moving forward, SWOG will be a clinical trials organization dedicated to conducting high-value, high-impact cancer trials.

描述（由申请人提供）：SWOG 是一个研究组织，癌症研究人员分布在美国、加拿大、拉丁美洲、韩国和沙特阿拉伯的 550 个学术和社区站点。该集团在开展临床试验方面有着悠久的历史，这些试验改变了肿瘤学实践的标准，并导致美国食品和药物管理局批准了新的抗肿瘤药物。 SWOG 的使命是设计、指导和参与临床试验，从而有效预防和治疗癌症，从而提高恶性肿瘤患者的生活质量和生存质量。用于帮助实现这些目标的指导原则包括将患者置于我们的最高优先级、利用最好的科学来推动我们的研究、拥抱成员和领导力的多样性、要求道德行为以及培养年轻的研究人员。 SWOG 对此应用程序的具体目标包括提高效率并快速执行临床试验开发和实施流程；广泛合作，减少应计障碍并促进参与 NCTN 试验；通过研究具有全球意义的癌症，最大限度地发挥国际合作伙伴的潜力；并成为 NCTN 管理的积极参与者和领导者。 SWOG 以我们成功的过去为基础，同时又不断向前发展，将成为一家致力于开展高价值、高影响力的癌症试验的临床试验组织。